Showing results (81-90 of 108) with videos related to

Sort By:
Pageof 11
Annals of Hematology|September 25, 2023
Down-regulation of Musashi-2 exerts antileukemic effects on acute lymphoblastic leukemia cells and increases sensitivity to dexamethasoneDuobing Zou, Mei Lv, Ying Chen, et al.
The Journal of International Medical Research|January 8, 2019
Clinically useful flow cytometry approach to identify immunophenotype in acute leukemiaGuifang Ouyang, Zhijuan Xu, Danjie Jiang, et al.
BMC Immunology|December 11, 2019
NK cell predicts the severity of acute graft-versus-host disease in patients after allogeneic stem cell transplantation using antithymocyte globulin (ATG) in pretreatment schemePing Zhang, Shujun Yang, Yujing Zou, et al.
Frontiers in Nutrition|March 24, 2023
Decreased transthyretin predicts a poor prognosis in primary myelodysplastic syndromeYing Chen, Tingting Niu, Ting Chen, et al.
Cell Discovery|January 8, 2024
Safety and feasibility of anti-CD19 CAR T cells expressing inducible IL-7 and CCL19 in patients with relapsed or refractory large B-cell lymphomaWen Lei, Ai Zhao, Hui Liu, et al.
BMC Cancer|February 1, 2022
Decreased serum apolipoprotein A1 level predicts poor prognosis of patients with de novo myelodysplastic syndromesCong Shi, Shengping Gong, An Wu, et al.
Bone Marrow Transplantation|May 25, 2021
Comparison of non-first-degree related donors and first-degree related donors in haploidentical HSCT: a multi-centre retrospective analysisYishan Ye, Mowang Wang, Florent Malard, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|September 22, 2025
Impact of clinical characteristics and genetic profiles on outcomes of allogeneic stem cell transplantation with sorafenib maintenance in <i>FLT3</i>-ITD acute myeloid leukemia patients: A multi-center, retrospective studyYeqian Zhao, Chuanhe Jiang, Yi Luo, et al.
American Journal of Hematology|June 10, 2026
CSF ctDNA Molecular Clearance as a Prognostic Biomarker for Orelabrutinib-Treated Primary Central Nervous System Lymphoma: Insights From Comparison With PET-CTLixia Sheng, Huijie Hu, Yanli Lai, et al.
Cancer|May 20, 2026
Integration of venetoclax into a fludarabine and melphalan conditioning regimen in patients aged 50 years and older with acute myeloid leukemia and myelodysplastic syndrome: Results from a phase 2 clinical trialXiaoyu Lai, Panpan Zhu, Luxin Yang, et al.
Pageof 11